{
  "ticker": "JNJ",
  "target_date": "2025-10-29",
  "actual_date": "2025-10-29",
  "collected_at": "2025-12-08T12:27:55.977142",
  "price": {
    "open": 185.52,
    "high": 185.92,
    "low": 183.49,
    "close": 185.42271423339844,
    "volume": 10551100,
    "change_1d_pct": -0.18,
    "change_7d_pct": -3.68,
    "change_30d_pct": 5.3
  },
  "technicals": {
    "rsi_14": 32.36,
    "sma_20": 189.13,
    "sma_50": 181.7,
    "macd": 2.008,
    "macd_signal": 3.068,
    "macd_histogram": -1.059,
    "bb_upper": 193.54,
    "bb_lower": 184.73,
    "price_vs_sma20_pct": -1.96,
    "price_vs_sma50_pct": 2.05,
    "volume_ratio": 1.27
  },
  "fundamentals": {
    "market_cap": 487693385728,
    "pe_ratio": 19.538765,
    "forward_pe": 19.096376,
    "price_to_book": 6.1438556,
    "price_to_sales": 5.2924438,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.59,
    "pct_from_52w_low": 43.89
  },
  "macro": {
    "spy": {
      "price": 687.39,
      "change_1d_pct": 0.05,
      "change_7d_pct": 2.4
    },
    "vix": {
      "level": 16.92,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.06
    },
    "dollar_index": {
      "level": 99.22
    },
    "gold": {
      "price": 3983.7
    },
    "regime": "BULL_LOW_VOL"
  },
  "news": [
    {
      "headline": "Ken Paxton Bellies Up to the Trial Bar",
      "source": "DowJones",
      "datetime": 1761759600,
      "summary": "Ken Paxton Bellies Up to the Trial Bar",
      "url": "https://finnhub.io/api/news?id=abdad0c01846cb4d89f98fdd07b5f4aef226d70be577b211c5cac0c875245fc9"
    },
    {
      "headline": "GSK's Q3 Earnings & Sales Beat Estimates, Stock Up on Raised '25 View",
      "source": "Yahoo",
      "datetime": 1761752880,
      "summary": "GSK's Q3 earnings and revenue beat expectations, powered by HIV and oncology growth, prompting the company to lift its 2025 outlook.",
      "url": "https://finnhub.io/api/news?id=52e063996463b426f039a994f6805dfd8580271516400b52f4572ce63aa1b5f5"
    },
    {
      "headline": "Johnson & Johnson announces first head-to-head study comparing IMAAVY\u2122 with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting",
      "source": "Yahoo",
      "datetime": 1761739500,
      "summary": "Johnson & Johnson (NYSE: JNJ) today announced plans to initiate the first head-to-head study comparing FcRn blockers for patients with generalized myasthenia gravis (gMG), which aims to affirm IMAAVY\u2122 (nipocalimab-aahu) as the FcRn blocker of choice for appropriate gMG patients. The EPIC study desig",
      "url": "https://finnhub.io/api/news?id=32a1fca05c55ef01615c338ca9600c78092bdd6ee9e3e18eac4c10c030a44ea3"
    },
    {
      "headline": "Best Dividend Kings: October 2025",
      "source": "SeekingAlpha",
      "datetime": 1761714686,
      "summary": "Dividend Kings are underperforming SPY in 2025, with a year-to-date return gap of 13.10%, but 12 Kings remain ahead of the index. Read more here.",
      "url": "https://finnhub.io/api/news?id=e88d07ba5881f7fac15aa768a04affc18b86c74fac7aa9fc28bbd4c57b8e173a"
    },
    {
      "headline": "Johnson & Johnson (JNJ) Price Target Increased by 10.96% to 204.02",
      "source": "Fintel",
      "datetime": 1761703985,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=09feab3eebd0ebe3598f49e45e72c94cbed2adca3bb592d39e03f0a7ec15604b"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "10-Q",
      "date": "2025-10-22",
      "description": "jnj-20250928.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/jnj-20250928.htm"
    },
    {
      "form": "4",
      "date": "2025-10-20",
      "description": "xslF345X05/wk-form4_1761002033.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000204/xslF345X05/wk-form4_1761002033.xml"
    },
    {
      "form": "8-K",
      "date": "2025-10-14",
      "description": "jnj-20251014.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000201/jnj-20251014.htm"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}